Eli Lilly will start research to see if its blockbuster weight-loss medicines can be used to deal with addictive behaviors like alcohol abuse, smoking and drug dependancy, CEO Dave Ricks stated to David Rubenstein on the Financial Membership of Washington, DC https://trib.al/ARzUbII
